ALDH1A2 antisense RNA 1 (ALDH1A2-AS1)

ALDH1A2 antisense RNA 1 (ALDH1A2-AS1) is a long non-coding RNA (lncRNA) transcribed from the antisense strand of the ALDH1A2 gene locus. As an antisense lncRNA, ALDH1A2-AS1 is presumed to regulate the expression of the neighboring protein-coding gene ALDH1A2, either by direct hybridization with the sense transcript (ALDH1A2 mRNA), by modulating chromatin structure, or through other epigenetic and post-transcriptional mechanisms. Hypermethylation and other epigenetic changes of many antisense lncRNAs, including those similar to ALDH1A2-AS1, have been observed in leukemias and may contribute to dysregulated expression of protein-coding genes, possibly acting as a driving event in malignant transformation or disease progression. Although ALDH1A2-AS1 is not a therapeutic target on its own, its methylation or expression status could be investigated as a biomarker in specific leukemias. The gene "ALDH1A2" encodes an enzyme (ALDH1A2/RALDH2) with important roles in development and cancer; however, "ALDH1A2-AS1" refers to the antisense non-coding RNA and not the enzyme itself. There is no evidence that the antisense RNA is directly druggable or acts as a receptor, enzyme, transporter, etc.

No approved or investigational drugs specifically target ALDH1A2-AS1; general lncRNA targeting strategies in preclinical research may include antisense oligonucleotides, RNAi, or epigenetic modulators.